Saturday 17 October 2026
Export LMAT’s income statement to Excel — free account
LeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.57%, EPS grew 23.0%, free cash flow fell 28.0% and total debt was flat, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
80.82
2.34
−2.81%
Follow LMAT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
31.68 | 46.77 | 42.01 | 47.82 | 39.55 | 38.57 | 39.94 | 20.03 | 34.58 | 44.26 |
Piotroski F-Score |
6 | 6 | 8 | 4 | 7 | 3 | 2 | 4 | 6 | 8 |
Altman Z-Score |
6.99 | 7.67 | 17.42 | 16.13 | 18.34 | 7.74 | 12.50 | 14.36 | 24.18 | 21.67 |
P/S ratio |
7.36 | 9.41 | 6.51 | 6.18 | 6.88 | 6.34 | 6.08 | 4.35 | 5.85 | 5.23 |
P/FCF ratio |
24.66 | 55.71 | 42.77 | 43.44 | 35.20 | 24.25 | 68.53 | 27.96 | 35.92 | 33.24 |
Altman Z″-Score (non-manufacturers) |
8.18 | 7.56 | 11.31 | 11.15 | 11.37 | 5.73 | 8.09 | 11.38 | 12.30 | 11.06 |
Beneish M-Score |
(2.61) | (3.52) | (2.36) | (2.49) | (2.50) | (2.53) | (2.28) | (2.36) | (2.62) | (2.55) |
P/Operating CF |
79.28 | 136.26 | 117.25 | 244.87 | 210.19 | 57.94 | 127.33 | 69.89 | 87.16 | 111.20 |
Dividend Safety Score |
93 | — | — | — | — | — | — | — | — | — |
P/B ratio |
4.67 | 6.13 | 4.23 | 3.72 | 4.18 | 4.75 | 4.81 | 3.53 | 5.38 | 5.33 |
Price to Tangible BV |
6.23 | 8.78 | 6.62 | 6.41 | 7.84 | 17.18 | 8.55 | 5.30 | 7.59 | 8.61 |
EV/Sales |
6.60 | 8.82 | 6.06 | 5.77 | 6.54 | 6.42 | 5.93 | 3.90 | 5.44 | 4.96 |
EV/EBITDA |
20.81 | 31.32 | 25.35 | 25.74 | 21.26 | 22.35 | 26.14 | 12.64 | 21.80 | 22.19 |
EV/Operating CF |
20.29 | 43.96 | 31.89 | 36.78 | 28.77 | 23.88 | 49.04 | 21.08 | 23.98 | 26.17 |
EV/FCF |
22.14 | 52.23 | 39.78 | 40.61 | 33.44 | 24.57 | 66.90 | 25.03 | 33.39 | 31.51 |
Quick Ratio |
10.81 | 10.77 | 4.36 | 4.13 | 4.11 | 1.85 | 2.36 | 3.22 | 4.30 | 3.58 |
Current Ratio |
12.89 | 13.14 | 6.51 | 6.39 | 6.41 | 3.75 | 4.42 | 4.76 | 6.09 | 5.63 |
Net Debt/EBITDA |
(2.40) | (2.13) | (2.27) | (1.87) | (1.18) | 0.30 | (0.64) | (1.47) | (1.66) | (1.22) |
Debt/Assets |
27.39% | 30.40% | 0.00% | 4.74% | 4.80% | 15.04% | 8.34% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.43 | 0.50 | 0.00 | 0.05 | 0.06 | 0.22 | 0.11 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.43 | 0.49 | 0.59 | 0.54 | 0.57 | 0.59 | 0.69 | 0.76 | 0.88 | 0.93 |
Operating CF/Net income |
1.41 | 1.00 | 1.22 | 1.23 | 1.30 | 1.64 | 0.79 | 0.85 | 1.33 | 1.60 |
Capex/Depreciation |
(0.60) | (0.72) | (0.76) | (0.25) | (0.44) | (0.11) | (0.69) | (0.71) | (1.58) | (0.79) |
Interest Coverage |
13.10 | 254.91 | — | — | 16.42 | 21.98 | — | 14,104.50 | 1,004.90 | 1,166.86 |
| 15.80% | 13.87% | 10.64% | 7.90% | 12.61% | 13.23% | 12.88% | 19.12% | 17.41% | 12.81% | |
| 9.89% | 9.80% | 9.16% | 6.84% | 9.86% | 9.62% | 10.51% | 16.42% | 15.05% | 11.00% | |
ROIC |
20.90% | 15.91% | 11.90% | 8.37% | 11.48% | 9.80% | 10.09% | 21.44% | 19.36% | 16.15% |
Return on Tangible Assets |
12.58% | 11.11% | 16.14% | 13.37% | 19.91% | 25.22% | 20.83% | 25.97% | 21.61% | 18.72% |
Average Days of Receivables |
49.15 | 49.91 | 47.28 | 49.77 | 46.40 | 55.17 | 51.60 | 54.36 | 54.28 | 54.01 |
Research and Development Expense of Revenue |
5.66% | 7.12% | 8.77% | 8.22% | 7.64% | 7.81% | 7.91% | 7.76% | 6.58% | 6.89% |
Selling, General and Administrative Expense of Revenue |
38.66% | 37.75% | 37.67% | 38.15% | 34.42% | 35.71% | 42.13% | 42.63% | 42.59% | 45.38% |
Intangible Assets out of Total Assets |
0.16 | 0.18 | 0.31 | 0.36 | 0.41 | 0.49 | 0.34 | 0.28 | 0.25 | 0.33 |
Share Based Compensation of Revenue |
3.14% | 2.99% | 2.75% | 2.58% | 2.25% | 2.34% | 2.25% | 2.23% | 2.24% | 1.88% |
Graham Net Nets |
0.13 | 0.09 | 0.12 | 0.12 | 0.10 | 0.02 | 0.07 | 0.16 | 0.11 | 0.10 |
Graham Number |
31.64 | 25.80 | 20.18 | 16.15 | 18.53 | 14.19 | 12.30 | 13.34 | 10.83 | 7.79 |
Earnings Yield |
3.16% | 2.14% | 2.38% | 2.09% | 2.53% | 2.59% | 2.50% | 4.99% | 2.89% | 2.26% |
Free Cash Flow Yield |
4.05% | 1.80% | 2.34% | 2.30% | 2.84% | 4.12% | 1.46% | 3.58% | 2.78% | 3.01% |
Revenue per Share |
11.03 | 9.79 | 8.71 | 7.36 | 7.30 | 6.39 | 5.92 | 5.43 | 5.32 | 4.82 |
Operating CF per Share |
3.59 | 1.97 | 1.65 | 1.15 | 1.66 | 1.72 | 0.72 | 1.00 | 1.21 | 0.91 |
Capex per Share |
(0.30) | (0.31) | (0.33) | (0.11) | (0.23) | (0.05) | (0.19) | (0.16) | (0.34) | (0.15) |
Free Cash Flow per Share |
3.29 | 1.66 | 1.33 | 1.05 | 1.43 | 1.67 | 0.53 | 0.85 | 0.87 | 0.76 |
Cash per Share |
15.86 | 13.35 | 4.73 | 3.76 | 3.31 | 1.33 | 1.65 | 2.47 | 2.20 | 1.31 |
Shareholders Equity per Share |
17.38 | 15.02 | 13.41 | 12.20 | 12.01 | 8.52 | 7.48 | 6.70 | 5.79 | 4.73 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.38 | 15.02 | 13.41 | 12.20 | 12.01 | 8.52 | 7.48 | 6.70 | 5.79 | 4.73 |
Free Cash Flow |
74.47 | 37.16 | 29.49 | 23.01 | 30.22 | 33.84 | 10.42 | 16.45 | 16.45 | 14.05 |
Working Capital |
431.91 | 371.59 | 164.72 | 136.40 | 118.07 | 69.12 | 71.24 | 74.26 | 67.12 | 48.55 |
Capital Expenditures |
(6.78) | (6.96) | (7.26) | (2.37) | (4.88) | (0.96) | (3.76) | (3.05) | (6.42) | (2.84) |
Net Current Asset Value |
246.06 | 187.67 | 145.72 | 119.46 | 101.23 | 14.03 | 51.89 | 71.16 | 63.76 | 44.60 |
EV/EBIT |
24.27 | 37.12 | 31.92 | 34.79 | 27.72 | 28.87 | 32.82 | 14.58 | 25.99 | 27.06 |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.01 | 0.03 | 0.01 | 0.03 | 0.03 | 0.06 | 0.03 |
Price to Operating Income |
27.03 | 39.59 | 34.32 | 37.21 | 29.18 | 28.48 | 33.63 | 16.28 | 27.96 | 28.55 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 0.39 | 0.44 | 0.53 | 0.65 | 0.56 | 0.36 | 0.31 | 0.33 | 0.45 |
Cash ROIC |
8.08% | 4.62% | 7.32% | 6.29% | 8.94% | 14.24% | 5.30% | 9.23% | 10.86% | 12.57% |
Accounts Receivable Turnover |
7.84 | 7.98 | 8.22 | 7.76 | 7.88 | 7.16 | 7.26 | 6.87 | 7.16 | 7.09 |
Accounts Payable Turnover |
26.29 | 25.10 | 20.02 | 21.65 | 22.41 | 17.91 | 17.24 | 19.32 | 21.86 | 20.30 |
Inventory Turnover |
1.05 | 1.12 | 1.23 | 1.18 | 1.16 | 1.06 | 1.12 | 1.31 | 1.49 | 1.51 |
Average Days of Payables |
18.73 | 9.32 | 20.51 | 18.67 | 16.10 | 19.53 | 25.43 | 19.99 | 18.67 | 16.94 |
Days of Inventory on Hand |
361.71 | 343.64 | 319.10 | 323.30 | 317.26 | 367.99 | 385.97 | 316.06 | 254.62 | 272.59 |
Average Receivables |
31.84 | 27.56 | 23.55 | 20.84 | 19.59 | 18.06 | 16.15 | 15.36 | 14.10 | 12.58 |
Average Payables |
2.70 | 2.75 | 3.32 | 2.62 | 2.37 | 2.50 | 2.17 | 1.64 | 1.38 | 1.29 |
Average Inventory |
67.67 | 61.50 | 54.18 | 48.19 | 45.61 | 42.32 | 33.46 | 24.22 | 20.31 | 17.39 |
Average Assets |
583.75 | 449.30 | 328.63 | 301.64 | 272.81 | 220.58 | 170.71 | 139.71 | 114.12 | 96.31 |
Average Common Equity |
365.40 | 317.60 | 283.05 | 261.18 | 213.36 | 160.36 | 139.19 | 120.00 | 98.64 | 82.69 |
Columns are period end dates